Healthcare Regulatory Enforcement & Fraud Defense

While federal and state agencies have recently increased their emphasis on investigating healthcare fraud, Latham & Watkins’ lawyers have dramatically helped healthcare clients avoid fines, incarceration, and other penalties.

Why Latham

Latham & Watkins has defended US-based clients, including the largest hospital system in the country, in several of the largest healthcare fraud investigations involving the highest level of complexity and amounts in controversy. 

A Powerful Combination of Regulatory and Trial Knowledge

By combining practitioners from Latham's Healthcare and Life Sciences Practice with its White Collar Defense & Investigations Practice, the firm is able to provide clients with comprehensive counsel in healthcare regulatory enforcement matters and government fraud investigations. The effective defense of complex healthcare regulatory enforcement and fraud investigations requires knowledge in three practice areas:

  • Substantive healthcare fraud and abuse laws and regulations
  • Civil False Claims Act and qui tam litigation
  • Criminal law and procedure

Latham's team of healthcare regulatory and reimbursement practitioners, seasoned civil litigators and experienced criminal trial lawyers brings the optimal defense experience and trial skills to each matter. Not only do Latham lawyers have unmatched experience in reaching negotiated resolutions of such matters, but the firm's trial experience provides clients with additional strategic options.

Scope of Services
  • Assisting in voluntary disclosures
  • Conducting internal investigations
  • Defending civil False Claims Act and qui tam litigation
  • Defending criminal and civil government healthcare fraud investigations
  • Development of compliance programs
  • Negotiating Corporate Integrity Agreements
  • Responding to Grand Jury subpoenas and search warrants
  • Strategic counseling in fraud and abuse laws

Awards & Rankings

  • Litigation & Trial Partner Named Healthcare Trailblazer - May 13, 2019
  • Latham Named Life Sciences Practice Group of the Year - January 27, 2019
"Tremendous experience with complex and sensitive investigations."
Chambers USA 2013

Media Coverage

Litigation & Trial Partner Named Healthcare TrailblazerWashington's Best Lawyers


FDA Regulatory Considerations for Tobacco and Cannabis-Derived SubstancesLitigation & Trial Partner Named National Law Journal Healthcare TrailblazerLatham Named Life Sciences Practice Group of the Year

Thought Leadership

OIG Provides Regulatory Considerations for Gainsharing Agreements in Advisory Opinion 17-09Still Useful? Senate Finance Evaluates Possible Stark Law Changes, Including RepealAl Mirsal Blog - Infographic: How Healthcare is Regulated in the UAE